Rosen, leading investor counsel, encourages renovaro biosciences inc. investors to inquire about securities class action investigation - renb

New york , feb. 25, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of renovaro biosciences inc. (nasdaq: renb) resulting from allegations that renovaro may have issued materially misleading business information to the investing public. so what: if you purchased renovaro securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
RENB Ratings Summary
RENB Quant Ranking